172 related articles for article (PubMed ID: 33322037)
1. Activation of the Ion Channel TRPV4 Induces Epithelial to Mesenchymal Transition in Breast Cancer Cells.
Azimi I; Robitaille M; Armitage K; So CL; Milevskiy MJG; Northwood K; Lim HF; Thompson EW; Roberts-Thomson SJ; Monteith GR
Int J Mol Sci; 2020 Dec; 21(24):. PubMed ID: 33322037
[TBL] [Abstract][Full Text] [Related]
2. Oncosis and apoptosis induction by activation of an overexpressed ion channel in breast cancer cells.
Peters AA; Jamaludin SYN; Yapa KTDS; Chalmers S; Wiegmans AP; Lim HF; Milevskiy MJG; Azimi I; Davis FM; Northwood KS; Pera E; Marcial DL; Dray E; Waterhouse NJ; Cabot PJ; Gonda TJ; Kenny PA; Brown MA; Khanna KK; Roberts-Thomson SJ; Monteith GR
Oncogene; 2017 Nov; 36(46):6490-6500. PubMed ID: 28759041
[TBL] [Abstract][Full Text] [Related]
3. A role for calcium in the regulation of ATP-binding cassette, sub-family C, member 3 (ABCC3) gene expression in a model of epidermal growth factor-mediated breast cancer epithelial-mesenchymal transition.
Stewart TA; Azimi I; Thompson EW; Roberts-Thomson SJ; Monteith GR
Biochem Biophys Res Commun; 2015 Mar; 458(3):509-514. PubMed ID: 25666946
[TBL] [Abstract][Full Text] [Related]
4. Induction of epithelial-mesenchymal transition (EMT) in breast cancer cells is calcium signal dependent.
Davis FM; Azimi I; Faville RA; Peters AA; Jalink K; Putney JW; Goodhill GJ; Thompson EW; Roberts-Thomson SJ; Monteith GR
Oncogene; 2014 May; 33(18):2307-16. PubMed ID: 23686305
[TBL] [Abstract][Full Text] [Related]
5. Calcium influx through TRPV4 channels involve in hyperosmotic stress-induced epithelial-mesenchymal transition in tubular epithelial cells.
Miyano T; Suzuki A; Sakamoto N
Biochem Biophys Res Commun; 2022 Aug; 617(Pt 2):48-54. PubMed ID: 35689842
[TBL] [Abstract][Full Text] [Related]
6. TRPV4 regulates matrix stiffness and TGFβ1-induced epithelial-mesenchymal transition.
Sharma S; Goswami R; Zhang DX; Rahaman SO
J Cell Mol Med; 2019 Feb; 23(2):761-774. PubMed ID: 30450767
[TBL] [Abstract][Full Text] [Related]
7. Pharmacological activation of TRPV4 produces immediate cell damage and induction of apoptosis in human melanoma cells and HaCaT keratinocytes.
Olivan-Viguera A; Garcia-Otin AL; Lozano-Gerona J; Abarca-Lachen E; Garcia-Malinis AJ; Hamilton KL; Gilaberte Y; Pueyo E; Köhler R
PLoS One; 2018; 13(1):e0190307. PubMed ID: 29293584
[TBL] [Abstract][Full Text] [Related]
8. TRPV4 Contributes to Resting Membrane Potential in Retinal Müller Cells: Implications in Cell Volume Regulation.
Netti V; Fernández J; Kalstein M; Pizzoni A; Di Giusto G; Rivarola V; Ford P; Capurro C
J Cell Biochem; 2017 Aug; 118(8):2302-2313. PubMed ID: 28098409
[TBL] [Abstract][Full Text] [Related]
9. TRPC1 is a differential regulator of hypoxia-mediated events and Akt signalling in PTEN-deficient breast cancer cells.
Azimi I; Milevskiy MJG; Kaemmerer E; Turner D; Yapa KTDS; Brown MA; Thompson EW; Roberts-Thomson SJ; Monteith GR
J Cell Sci; 2017 Jul; 130(14):2292-2305. PubMed ID: 28559303
[TBL] [Abstract][Full Text] [Related]
10. THE ROLE OF TRPV4 CATION CHANNELS IN THE REGULATION OF PHENYLEPHRINE-INDUCED CONTRACTION OF RAT PULMONARY ARTER.
Dryn D; Melnyk M; Kizub I; Hu H; Soloviev A; Zholos A
Fiziol Zh (1994); 2016; 62(2):79-86. PubMed ID: 29537229
[TBL] [Abstract][Full Text] [Related]
11. Characterization of transient receptor potential vanilloid channel 4 (TRPV4) in human corneal endothelial cells.
Mergler S; Valtink M; Taetz K; Sahlmüller M; Fels G; Reinach PS; Engelmann K; Pleyer U
Exp Eye Res; 2011 Nov; 93(5):710-9. PubMed ID: 21996372
[TBL] [Abstract][Full Text] [Related]
12. Endothelial TRPV4 channels modulate vascular tone by Ca
Heathcote HR; Lee MD; Zhang X; Saunter CD; Wilson C; McCarron JG
Br J Pharmacol; 2019 Sep; 176(17):3297-3317. PubMed ID: 31177523
[TBL] [Abstract][Full Text] [Related]
13. P2Y1 Receptor Activation of the TRPV4 Ion Channel Enhances Purinergic Signaling in Satellite Glial Cells.
Rajasekhar P; Poole DP; Liedtke W; Bunnett NW; Veldhuis NA
J Biol Chem; 2015 Nov; 290(48):29051-62. PubMed ID: 26475857
[TBL] [Abstract][Full Text] [Related]
14. Altered purinergic receptor-Ca²⁺ signaling associated with hypoxia-induced epithelial-mesenchymal transition in breast cancer cells.
Azimi I; Beilby H; Davis FM; Marcial DL; Kenny PA; Thompson EW; Roberts-Thomson SJ; Monteith GR
Mol Oncol; 2016 Jan; 10(1):166-78. PubMed ID: 26433470
[TBL] [Abstract][Full Text] [Related]
15. Hydrogen sulfide-induced vasodilation mediated by endothelial TRPV4 channels.
Naik JS; Osmond JM; Walker BR; Kanagy NL
Am J Physiol Heart Circ Physiol; 2016 Dec; 311(6):H1437-H1444. PubMed ID: 27765747
[TBL] [Abstract][Full Text] [Related]
16. Transient receptor potential vanilloid 4-dependent calcium influx and ATP release in mouse and rat gastric epithelia.
Mihara H; Suzuki N; Boudaka AA; Muhammad JS; Tominaga M; Tabuchi Y; Sugiyama T
World J Gastroenterol; 2016 Jun; 22(24):5512-9. PubMed ID: 27350729
[TBL] [Abstract][Full Text] [Related]
17. EGF induces epithelial-mesenchymal transition through phospho-Smad2/3-Snail signaling pathway in breast cancer cells.
Kim J; Kong J; Chang H; Kim H; Kim A
Oncotarget; 2016 Dec; 7(51):85021-85032. PubMed ID: 27829223
[TBL] [Abstract][Full Text] [Related]
18. Pharmacological inhibition of TRPV4 channel suppresses malignant biological behavior of hepatocellular carcinoma via modulation of ERK signaling pathway.
Fang Y; Liu G; Xie C; Qian K; Lei X; Liu Q; Liu G; Cao Z; Fu J; Du H; Liu S; Huang S; Hu J; Xu X
Biomed Pharmacother; 2018 May; 101():910-919. PubMed ID: 29635900
[TBL] [Abstract][Full Text] [Related]
19. TRPP2 and TRPV4 form an EGF-activated calcium permeable channel at the apical membrane of renal collecting duct cells.
Zhang ZR; Chu WF; Song B; Gooz M; Zhang JN; Yu CJ; Jiang S; Baldys A; Gooz P; Steele S; Owsianik G; Nilius B; Komlosi P; Bell PD
PLoS One; 2013; 8(8):e73424. PubMed ID: 23977387
[TBL] [Abstract][Full Text] [Related]
20. The effect of transient receptor potential vanilloid 4 on the intestinal epithelial barrier and human colonic cells was affected by tyrosine-phosphorylated claudin-7.
Huang YY; Li J; Zhang HR; Bai SW; Yang HY; Shen B; Du J; Xia XM
Biomed Pharmacother; 2020 Feb; 122():109697. PubMed ID: 31918271
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
